Objective assessment of transcatheter arterial chemoembolization angiographic endpoints: preliminary study of quantitative digital subtraction angiography. 2013

Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

OBJECTIVE To explore the significance of quantitative digital subtraction angiography (DSA; Q-DSA) in the assessment of chemoembolization endpoints. METHODS Twenty patients with hepatocellular carcinoma treated with chemoembolization were included in the study. All DSA series before and after chemoembolization were postprocessed with Q-DSA. The maximal enhancement and time to peak (TTP) were measured for several homologous anatomic landmarks, including the origin and embolized site of the tumor-feeding artery, parenchyma of the tumor, and ostia of the pre- and postprocedure catheter. The TTP, tumor blood supply time, and maximal enhancement of the time density curve (TDC) were analyzed. RESULTS Of the 20 DSA series collected, 18 were successfully postprocessed. The TTPs of the landmarks before and after treatment were 3.60 seconds±1.02 and 3.57 seconds±0.78 at the ostia of the catheter, 3.91 seconds±1.01 and 4.09 seconds±1.14 at the origin site of the tumor-feeding artery, and 4.07 seconds±1.02 and 5.60 seconds±1.56 s the embolized site of the main tumor-feeding artery, respectively. Statistical differences were detected between pre- and postprocedural TTP of the embolized site of the feeding artery (P<.01), as well as between pre- and postprocedural tumor blood supply time (P<.01). The mean maximal TDC enhancements of selected tumor spots were 3.01 units±1.04 and 0.81 units±0.35 before and after the procedure (P<.01), respectively. CONCLUSIONS Q-DSA may provide a feasible quantitative measurement in the assessment of chemoembolization endpoints.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011857 Radiographic Image Interpretation, Computer-Assisted Computer systems or networks designed to provide radiographic interpretive information. Computer Assisted Radiographic Image Interpretation,Computer-Assisted Radiographic Image Interpretation,Radiographic Image Interpretation, Computer Assisted
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
November 2011, AJR. American journal of roentgenology,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
November 2016, Cardiovascular and interventional radiology,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
September 1984, American heart journal,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
June 1983, Journal of neurosurgery,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
June 1986, La Radiologia medica,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
June 1985, Radiologic clinics of North America,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
December 1986, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
January 1989, Radiation medicine,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
August 1981, Nederlands tijdschrift voor geneeskunde,
Xue-bin Zhang, and Zhi-Guo Zhuang, and Hui Ye, and Janina Beilner, and Markus Kowarschik, and Jie-jun Chen, and Jia-chang Chi, and Jian-rong Xu
July 2023, Medical physics,
Copied contents to your clipboard!